Brand name authorized in: Hong Kong
The drug ACRASON contains a combination of these active pharmaceutical ingredients (APIs):
Clotrimazole acts against fungi by inhibiting ergosterol synthesis. Inhibition of ergosterol synthesis leads to structural and functional impairment of the fungal cytoplasmic membrane. Clotrimazole has a broad antimycotic spectrum of action in vitro and in vivo, which includes dermatophytes, yeasts, moulds, etc.
This drug has been assigned below unique identifiers within the countries it is being marketed: